Human CD19+ B Cells (10 Million Cells, Negative Selection)
Human CD19+ B Cells (10 Million Cells, Negative Selection)
Human CD19+ B cells isolated from peripheral blood using negative immunomagnetic selection, cryopreserved, ≥10 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
You May Also Need...
Product Overview
Leukapheresed CD19+ B cells are negatively selected from leukapheresed peripheral blood MNCs using an immunomagnetic labeling system to remove unwanted cell types leaving the B cells untouched. Cells are cryopreserved in Lonza Cryo Media in a cryovial. Cell purity is determined post thaw using a FACS assay. Count and viability is determined using AO/PI. Cells are collected from healthy donors following IRB protocols.
Request More InfoApplications
- Generating antibody libraries
- Co-culture with T helper cells or cytotoxic lymphocytes (CTL)
- B cell activation, clonal expansion, Ig rearrangement, and Ig secretion
- Antigen presenting cell (APC) signal transduction and antigen presentation
Storage and Content
1 vial containing ≥ 10 million cryopreserved cellsSDS, CoA, and Instructions
Safety Data Sheets (SDS)
Choose a language to view the SDS.
Certificate of Analysis (CoA)
Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.
